CHAMBER HILL STRATEGIES

Lobbying for MARSHALL BIORESOURCES · commercial animal breeder

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $50,000.00 income · posted Jul 19, 2026

Bills named in this filing 2

Lobbying activity 1

Health Issues

S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.